References
1a
Katrizky AR.
Ress CW.
Scriven EFV. In Comprehensive Heterocyclic Chemistry II
Pergamon Press;
Oxford UK:
1996.
1b
Lecount DJ.
Progress in Heterocyclic Chemistry
1998,
10:
320
2a
Shimizu Y.
Chou HN.
Bando H.
Van Duyne G.
Clardy JC.
J. Am. Chem. Soc.
1986,
108:
514
2b
Pawlak M.
Tempesta MS.
Golik J.
Zagorski MG.
Lee MS.
Nakanishi K.
Iwashita T.
Gross ML.
Tomer KB.
J. Am. Chem. Soc.
1987,
109:
1144
3
Murata M.
Legrand AM.
Ishibashi Y.
Yasumoto T.
J. Am. Chem. Soc.
1989,
111:
8929
4a
Nicolaou KC.
Hwang CK.
Duggan ME.
Bal Reddy K.
Tetrahedron Lett.
1987,
28:
1501
4b
Paquette LA.
Sweeney TJ.
Tetrahedron
1990,
46:
4487
4c
Clark DL.
Chou W.-N.
White JB.
J. Org. Chem.
1990,
55:
3975
4d
Clark JS.
Krowiak SA.
Street LJ.
Tetrahedron Lett.
1993,
34:
4385
4e
Robinson RA.
Clark JS.
Holmes AB.
J. Am. Chem. Soc.
1993,
115:
10400
4f
Clark JS.
Whitlock GA.
Tetrahedron Lett.
1994,
35:
6381
4g
Clark JS.
Dossetter AG.
Whittingham WG.
Tetrahedron Lett.
1996,
37:
5605
4h
Clark JS.
Fretwell M.
Whitlock GA.
Burns CJ.
Fox DNA.
Tetrahedron Lett.
1998,
39:
97
4i
Bueno AB.
Moser WH.
Hegedus LS.
J. Org. Chem.
1998,
63:
1462
4j
Xie RL.
Hauske JR.
Tetrahedron Lett.
2000,
41:
10167
4k
Wang EC.
Hsu MK.
Huang KS.
Heterocycles
2002,
57:
1997
4l
Peczuh MW.
Snyder NL.
Tetrahedron Lett.
2003,
44:
4057
4m
Kulesza A.
Ebetino FH.
Mazur AW.
Tetrahedron Lett.
2003,
44:
5511
5a
Jeong I.-Y.
Nagao Y.
Tetrahedron Lett.
1998,
39:
8677
5b
Jeong I.-Y.
Lee WS.
Goto S.
Sano S.
Shiro M.
Nagao Y.
Tetrahedron
1998,
54:
14437
5c
Jeong I.-Y.
Nagao Y.
Synlett
1999,
576
5d
Jeong I.-Y.
Shiro M.
Nagao Y.
Heterocycles
2000,
52:
85
5e
Nagao Y.
Tanaka S.
Ueki A.
Jeong I.-Y.
Sano S.
Shiro M.
Synlett
2002,
480:
5f
Nagao Y.
Ueki A.
Asano K.
Tanaka S.
Sano S.
Shiro M.
Org. Lett.
2002,
4:
455
5g
Nagao Y.
Sano S.
J. Synth. Org. Chem., Jpn.
2003,
61:
1088
6
Bell VL.
Giddings PJ.
Holmes AB.
Mock GA.
Raphael RA.
J. Chem. Soc., Perkin Trans. 1
1986,
1515
7a
Mohler DL.
Thompson DW.
Tetrahedron Lett.
1987,
28:
2567
7b
Schultz AG.
Kirincich SJ.
J. Org. Chem.
1996,
61:
5631
7c
Kinder MA.
Kopf J.
Margaretha P.
Tetrahedron
2000,
56:
6763
8
Noureldin NA.
Zhao D.
Lee DG.
J. Org. Chem.
1997,
62:
8767
9a
Weiberth FJ.
Hall SS.
J. Org. Chem.
1997,
62:
6450
9b
Zimmer R.
Synthesis
1993,
165
9c
Pulz R.
Synlett
2000,
1697
10
Typical Experimental Procedure for the Synthesis of Hydroxy Methoxyallenyl-4,4-dialkylisochromans 7a-c: A solution of methoxyallene (280.4 mg, 4.0 mmol) in dry THF (4.0 mL) was treated with 1.58 M n-BuLi in n-hexane (1.52 mL, 2.4 mmol) under an argon atmosphere at -30 °C. The solution was stirred for 30 min, and then the solution was added to a THF (2.0 mL) solution of 4,4-dimethyl-isochroman-1-one (6a; 352.4 mg, 2.0 mmol) at -30 °C. After being stirred at -30 °C for 1 h, the reaction mixture was quenched with H2O and extracted with Et2O. The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was evaporated in vacuo to afford a crude product, which was purified by column chromato-graphy on silica gel with n-hexane-EtOAc (3:1) to give 1-hydroxy-1-methoxyallenyl-4,4-dimethylisochroman (7a; 483.2 mg, 98%) as a pale yellow oil.
Compound 7a: pale yellow oil. IR (neat): 3428, 1956 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.26 (s, 3 H), 1.33 (s, 3 H), 3.42 (s, 1 H), 3.47 (s, 3 H), 3.61 (d, J = 11.0 Hz, 1 H), 4.04 (d, J = 11.0 Hz, 1 H), 5.60 (d, J = 8.3 Hz, 1 H), 5.66 (d, J = 8.3 Hz, 1 H), 7.17-7.36 (m, 4 H). 13C NMR (75 MHz, CDCl3): δ = 24.5, 28.2, 33.4, 56.8, 70.8, 94.3, 96.1, 124.4, 125.7, 127.4, 128.5, 133.7, 137.2, 144.1, 197.1. HRMS-EI calcd for C15H18O3: MW 246.1256. Found: m/z = 246.1254 (M+). Compound 7b: pale yellow oil. IR (neat): 3470, 1956 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.77 (t, J = 7.7 Hz, 3 H), 0.81 (t, J = 7.7 Hz, 3 H), 1.62-1.82 (m, 4 H), 3.48 (s, 3 H), 3.50 (s, 1 H), 3.76 (d, J = 11.2 Hz, 1 H), 4.11 (d, J = 11.2 Hz, 1 H), 5.52 (d, J = 8.3 Hz, 1 H), 5.55 (d, J = 8.3 Hz, 1 H), 7.16-7.31 (m, 3 H), 7.36-7.39 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 8.6, 8.7, 28.5, 31.3, 39.4, 56.9, 66.5, 94.0, 96.3, 125.5, 125.6, 127.6, 128.0, 135.2, 136.7, 141.2, 197.4. HRMS-EI calcd for C17H22O3: MW 274.1569. Found: m/z = 274.1569 (M+). Compound 7c: white powder. IR (KBr): 3420, 1957 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.83 (t, J = 7.3 Hz, 3 H), 0.86 (t, J = 7.3 Hz, 3 H), 1.06-1.29 (m, 4 H), 1.59-1.73 (m, 4 H), 3.48 (s, 3 H), 3.49 (s, 1 H), 3.76 (d, J = 11.5 Hz, 1 H), 4.10 (d, J = 11.5 Hz, 1 H), 5.52 (d, J = 8.3 Hz, 1 H), 5.55 (d, J = 8.3 Hz, 1 H), 7.15-7.30 (m, 3 H), 7.35-7.37 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 14.9, 15.0, 17.3, 17.4, 39.2, 39.4, 41.7, 57.0, 67.4, 94.1, 96.3, 125.4, 125.5, 127.6, 128.0, 134.7, 136.6, 141.9, 197.3. HRMS-EI calcd for C19H26O3: MW 302.1882. Found: m/z = 302.1888 (M+).
11
Typical Procedure for the Ring-Expansion Reaction of Hydroxy Methoxyallenyl-4,4-dialkylisochromans 7a-c: A mixture of 1-hydroxy-1-methoxyallenyl-4,4-dimethyl-isochroman (7a; 173.1 mg, 0.703 mmol), Pd(PPh3)4 (40.6 mg, 5.0 mol%), P(o-tolyl)3 (21.4 mg, 10.0 mol%) in THF (7.0 mL) was refluxed under an argon atmosphere for 3 h. The reaction mixture was evaporated in vacuo to afford a solid residue, which was purified by column chromato-graphy on silica gel with n-hexane-EtOAc (3:1) to give 5,5-dimethyl-2-methoxy-2-vinyl-3-benzoxepan-1-one (8a; 137.4 mg, 79%) as colorless prisms.
Compound 8a: colorless prisms; mp 78.5-79.5 °C (n-hexane-EtOAc). IR (KBr): 1711 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.14 (s, 3 H), 1.60 (s, 3 H), 3.36 (s, 3 H), 3.69 (d, J = 13.2 Hz, 1 H), 4.03 (d, J = 13.2 Hz, 1 H), 5.37 (dd, J = 1.6, 10.3 Hz, 1 H), 5.53 (dd, J = 1.6, 17.3 Hz, 1 H), 5.65 (dd, J = 10.3, 17.3 Hz, 1 H), 7.21-7.25 (m, 1 H), 7.41-7.50 (m, 3 H). HRMS-EI calcd for C15H18O3: MW 246.1256. Found: m/z = 246.1258 (M+). Anal. Calcd for C15H18O3: C, 73.15; H, 7.37. Found: C, 73.03; H, 7.38. Compound 8b: colorless oil. IR (neat): 1700 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.46 (t, J = 7.5 Hz, 3 H), 1.07 (t, J = 7.5 Hz, 3 H) 1.44-1.58 (m, 2 H), 1.76-1.89 (m, 1 H), 2.13-2.23 (m, 1 H), 3.35 (s, 3 H), 3.86 (d, J = 13.7 Hz, 1 H), 4.10 (d, J = 13.7 Hz, 1 H), 5.35 (dd, J = 1.5, 10.5 Hz, 1 H), 5.48 (dd, J = 1.5, 17.3 Hz, 1 H), 5.62 (dd, J = 10.5, 17.3 Hz, 1 H), 7.22-7.26 (m, 1 H), 7.24 (d, J = 7.8 Hz, 1 H), 7.42 (dd, J = 1.5, 7.7 Hz, 1 H), 7.46-7.50 (m, 1 H). HRMS-EI calcd for C17H22O3: MW 274.1569. Found: m/z = 274.1558 (M+). Anal. Calcd for C17H22O3: C, 74.42; H, 8.08. Found: C, 74.17; H, 8.08. Compound 8c: colorless oil. IR (neat): 1701 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.54-0.73 (m, 4 H), 0.92-1.04 (m, 4 H), 1.33-1.50 (m, 3 H), 1.63-1.78 (m, 3 H), 3.34 (s, 3 H), 3.87 (d, J = 13.7 Hz, 1 H), 4.11 (d, J = 13.7 Hz, 1 H), 5.35 (dd, J = 1.5, 10.5 Hz, 1 H), 5.48 (dd, J = 1.5, 17.3 Hz, 1 H), 5.61 (dd, J = 10.5, 17.3 Hz, 1 H), 7.21-7.24 (m, 1 H), 7.36 (d, J = 7.8 Hz, 1 H), 7.40 (dd, J = 1.5, 7.8 Hz, 1 H), 7.46-7.50 (m, 1 H). HRMS-EI calcd for C19H26O3: MW 302.1882. Found: m/z = 302.1888 (M+). Anal. Calcd for C19H26O3: C, 75.46; H, 8.67. Found: C, 75.21; H, 8.71.
12 X-ray data for 8a: C15H18O3, MW = 246.31, colorless block, orthorhombic, space group Aba2 (#41), a = 22.4114 Å, b = 7.929(2) Å, c = 14.737 (4) Å, V = 2618 (1) Å3, Z = 8, R = 0.181, Rw = 0.181. The structure factors are available from the author upon request.
13a
Bhide BH.
Shah KK.
Indian J. Chem., Sect. B
1980,
19:
9
13b
Lamaty G.
Moreau C.
Mouloungui Z.
Can. J. Chem.
1983,
61:
2643
13c
Isobe K.
Takeda N.
Mohri K.
Tsuda Y.
Chem. Pharm. Bull.
1989,
37:
3390
14
Typical Experimental Procedure for the Ring-Expansion Reaction of Isochroman-1-ones 9a-e: A solution of methoxyallene (140.2 mg, 2.0 mmol) in dry THF (2.0 mL) was treated with 1.58 M n-BuLi in n-hexane (0.76 mL, 1.2 mmol) under an argon atmosphere at -30 °C with stirring for 30 min. Then the solution was added to a THF (1.0 mL) solution of 7-methoxy-isochroman-1-one (9d; 178.2 mg, 1.0 mmol) at -30 °C. After being stirred at -30 °C for 1 h, the reaction mixture was quenched with H2O and extracted with Et2O. The organic layer was washed with brine, dried over MgSO4, and filtered. The filtrate was evaporated in vacuo to afford a crude product, which was purified by column chromatography on silica gel with n-hexane-EtOAc (3:1) to give 5,8-dimethoxy-4-methyl-1,2-dihydro-3-benzoxocin-6-one (10d; 166.6 mg, 69%) as colorless plates.
Compound 10a: colorless oil. IR (neat): 1619, 1596 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.12 (s, 3 H), 2.98 (t, J = 5.7 Hz, 2 H), 3.73 (s, 3 H), 4.02 (t, J = 5.7 Hz, 2 H), 7.16 (d, J = 7.6 Hz, 1 H), 7.35 (t, J = 7.6 Hz, 1 H), 7.44 (d, J = 7.6 Hz, 1 H), 7.74 (d, J = 7.6 Hz, 1 H). HRMS-EI calcd for C13H14O3: MW 218.0943. Found: m/z = 218.0957 (M+). Anal. Calcd for C13H14O3: C, 71.54; H, 6.47. Found: C, 71.32; H, 6.43. Compound 10b: colorless needles; mp 72.5-73.5 °C (CHCl3-n-hexane-Et2O). IR (KBr): 1620, 1601
cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.11 (s, 3 H), 2.36 (s, 3 H), 2.94 (t, J = 5.9 Hz, 2 H), 3.72 (s, 3 H), 4.00 (t, J = 5.9 Hz, 2 H), 7.05 (d, J = 7.8 Hz, 1 H), 7.23-7.26 (m, 1 H), 7.56 (d, J = 0.7 Hz, 1 H). HRMS-EI calcd for C14H16O3: MW 232.1100. Found: m/z = 232.1104 (M+). Anal. Calcd for C14H16O3: C, 72.39; H, 6.94. Found: C, 72.13; H, 6.96. Compound 10c: colorless prisms; mp 56.0-56.5 °C (n-hexane-Et2O). IR (KBr): 1617, 1608 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.11 (s, 3 H), 2.37 (s, 3 H), 2.95 (t, J = 5.7 Hz, 2 H), 3.72 (s, 3 H), 4.01 (t, J = 5.7 Hz, 2 H), 6.97 (s, 1 H), 7.15 (d, J = 8.1 Hz, 1 H), 7.69 (d, J = 8.1 Hz, 1 H); HRMS-EI calcd for C14H16O3: MW 232.1100. Found: m/z = 232.1092 (M+). Anal. Calcd for C14H16O3: C, 72.39; H, 6.94. Found: C, 72.17; H, 6.98. Compound 10d: colorless plates; mp 81.0 °C (n-hexane-EtOAc). IR (KBr): 1613, 1600 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.12 (s, 3 H), 2.92 (t, J = 5.6 Hz, 2 H), 3.72 (s, 3 H), 3.83 (s, 3 H), 3.99 (t, J = 5.6 Hz, 2 H), 7.00 (dd, J = 2.0, 8.3 Hz, 1 H), 7.07 (d, J = 8.3 Hz, 1 H), 7.30 (d, J = 2.0 Hz, 1 H). HRMS-EI calcd for C14H16O4: MW 248.1049. Found: m/z = 248.1049 (M+). Anal. Calcd for C14H16O4: C, 67.73; H, 6.50. Found: C, 67.76; H, 6.52. Compound 10e: colorless needless; mp 147.0-147.5 °C (n-hexane-EtOAc); IR (KBr) 1617, 1596 cm-1; 1H NMR (400 MHz, CDCl3) d = 2.11 (s, 3 H), 2.97 (t, J = 5.7 Hz, 2 H), 3.72 (s, 3 H), 3.92 (s, 3 H), 3.94 (s, 3 H), 4.03 (t, J = 5.7 Hz, 2 H), 6.62 (s, 1 H), 7.44 (s, 1 H). HRMS-EI calcd for C15H18O5 MW 278.1154, found m/z 278.1172 (M+). Anal. Calcd for C15H18O5: C, 64.47; H, 6.52. Found: C, 64.74; H, 6.58.
15 X-ray data for 10b: C14H16O3, MW = 232.28, colorless needle, monoclinic, space group P21/c (#14), a = 10.223(3) Å, b = 8.743(2) Å, c = 14.193(3) Å, V = 1237.9(5) Å3, β = 102.64(1)o, Z = 4, R = 0.087, Rw = 0.131. The structure factors are available from the author upon request.